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blaCTX-M-15 Gene on a Novel IncHI2 Plasmid
Samuel Kariuki,a,c Chinyere Okoro,c John Kiiru,a Samuel Njoroge,a Geoffrey Omuse,b Gemma Langridge,c Robert A. Kingsley,c
Gordon Dougan,c Gunturu Revathib
Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenyaa; Aga Khan University Hospital, Nairobi, Kenyab; The Wellcome Trust Sanger Institute,
Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdomc
Multidrug-resistant bacteria pose a major challenge to the clinical management of infections in resource-poor settings. Although
nontyphoidal Salmonella (NTS) bacteria cause predominantly enteric self-limiting illness in developed countries, NTS is respon-
sible for a huge burden of life-threatening bloodstream infections in sub-Saharan Africa. Here, we characterized nine S. Typhi-
murium isolates from an outbreak involving patients who initially failed to respond to ceftriaxone treatment at a referral hospi-
tal in Kenya. These Salmonella enterica serotype Typhimurium isolates were resistant to ampicillin, chloramphenicol,
cefuroxime, ceftriaxone, aztreonam, cefepime, sulfamethoxazole-trimethoprim, and cefpodoxime. Resistance to -lactams, in-
cluding to ceftriaxone, was associated with carriage of a combination of blaCTX-M-15, blaOXA-1, and blaTEM-1 genes. The genes en-
coding resistance to heavy-metal ions were borne on the novel IncHI2 plasmid pKST313, which also carried a pair of class 1 inte-
grons. All nine isolates formed a single clade within S. Typhimurium ST313, the major clone of an ongoing invasive NTS
epidemic in the region. This emerging ceftriaxone-resistant clone may pose a major challenge in the management of invasive
NTS in sub-Saharan Africa.
It is estimated that nontyphoidal Salmonella (NTS) causes100million cases of gastroenteritis every year, of which 155,000
are fatal (1). Although NTS predominantly causes localized gut
infections, invasive NTS (iNTS) infections may occur when the
bacteria spread beyond the mucosa to reach normally sterile sites,
such as the bloodstream, bones, joints, and the brain (2). A signif-
icant burden of iNTS cases are found in sub-Saharan Africa (3, 4),
causedmainly by Salmonella enterica serotypes Typhimurium and
Enteritidis (5, 6). Infections with these serotypes are associated
with poor outcomes, including a high rate of mortality, especially
among children less than 5 years of age and inHIV-infected adults
who have lowCD4T-lymphocyte counts (7, 8). Due to an increas-
ing prevalence of resistance to commonly available antibiotics,
extended-spectrum cephalosporins and fluoroquinolones now
are recommended for the management of iNTS (9). However,
these alternative antimicrobials are less widely available andmore
expensive to use in resource-limited settings. Although resistance
to first-line antimicrobials, such as ampicillin, chloramphenicol,
and cotrimoxazole, is common among NTS fromKenya and else-
where in sub-Saharan Africa, resistance to ceftriaxone and fluoro-
quinolones has been reported rarely.
Whole-genome sequence analysis of S. Typhimurium, isolated
in a number of countries in sub-Saharan Africa, has identified a
novel multilocus sequence type (MLST), ST313, which is respon-
sible for an ongoing epidemic in the region (10). These ST313 S.
Typhimurium strains fall into two related ST313 clades and en-
codemultidrug resistance (MDR), in part on integrons associated
with the invasion-associated plasmid pSLT. Here, we report the
isolation and genomic characterization of ST313 S. Typhimurium
isolates from patients seeking treatment in a tertiary-care and
teaching hospital in Nairobi, Kenya, that exhibited resistance to
ceftriaxone with or without combined resistance to fluoroquino-
lones.
MATERIALS AND METHODS
Patients andNTS strains.Adults and children reporting with fever to the
Aga Khan University Hospital in Nairobi, Kenya, and referred for blood
culture investigations between April 2009 and December 2011 were in-
cluded in this study (Table 1). These patients were admitted with severe
sepsis and failed treatment with routinely used antimicrobials, including
ceftriaxone. Meropenem or imipenem was used to treat the patients by
following Sanford guidelines (2012) on antimicrobial therapy (30).
Blood specimens from children and adults were inoculated into blood
culture media and incubated in a Bactec 9050 culture system (Becton,
Dickinson and Company). All positive blood cultures were subcultured
onto sheep blood agar, Salmonella-Shigella agar (SSA), and MacConkey
agar plates (Oxoid, Basingstoke, United Kingdom). In addition, fecal
samples from patients who had diarrhea initially were enriched in selenite
F broth and subcultured on MacConkey agar and SSA (Oxoid). Bacterial
isolates were identified by biochemical tests using API 20E strips (bio-
Mérieux, Basingstoke, United Kingdom) and serotyped using agglutinat-
ing antisera (Murex Diagnostics, Dartford, United Kingdom). S. Typhi-
murium isolates were stored at 70°C on Protect beads (Technical
Service Consultants Ltd., Heywood, United Kingdom).
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Antimicrobial susceptibility testing.NTS isolates were tested for sus-
ceptibility to antimicrobials by a controlled disk diffusion technique on
diagnostic sensitivity testing (DST) agar (Oxoid) plates. The antibiotic
discs (all fromOxoid) contained ampicillin (10 g), tetracycline (30 g),
cotrimoxazole (1:25 g), chloramphenicol (30 g), gentamicin (10 g),
coamoxyclav (20:10 g), ciprofloxacin (10 g), ceftriaxone (30 g), and
nalidixic acid (10 g). Escherichia coli ATCC 25922 was included to con-
trol for disc potency and quality of the culture media. Susceptibility tests
were interpreted using the Clinical and Laboratory Standards Institute
(CLSI) guidelines (11). In addition, MICs were performed with an auto-
mated bacteriology analyzer, Vitek Compact 2 (bioMérieux), using
Gram-negative card GN26, which had the following antimicrobials that
were clinically relevant to Salmonella spp.: ampicillin, ceftriaxone, cipro-
floxacin, cefepime, trimethoprim-sulfamethoxazole, and meropenem.
Cefpodoxime, cefoxitin, aztreonam, and ceftazidime are not clinically rel-
evant to management of iNTS infections but were used as extended-spec-
trum beta lactamase (ESBL) markers. Double disk synergy tests for ESBL
confirmation were performed using previously described methods (12).
Current CLSI updates on interpretation of ciprofloxacin susceptibility
cutoffs on Salmonella spp. were utilized when reporting susceptibility re-
sults of blood culture isolates to clinicians for management of patients.
Genomic DNA preparation. Bacteria for genomic analysis first were
grown on Luria-Bertani (LB) medium (Oxoid) by inoculating a single
isolated colony into broth, followed by incubation overnight at 37°C. The
bacterial growth was pelleted by centrifugation, and whole-genome DNA
was extracted using the Wizard genomic DNA kit (Promega, Southamp-
ton, United Kingdom). Aliquots of 20 to 50 ng/l of DNA from each
isolate were submitted for whole-genome sequencing.
Library preparation and DNA sequencing. Multiplex libraries with
108-bp reads and amean insert size of 272 bp were prepared as previously
described (13). The cluster formation, primer hybridization, and se-
quencing reactions were performed using the Illumina Hiseq sequencer
(LGC, Middlesex, United Kingdom). The resulting short-read sequences
were deposited in the European Nucleotide Archive; accession numbers
for the whole genome are listed below. An average of 91.7% of each strain
was mapped using SMALT with a mean depth of 118.6-fold coverage in
mapped regions across all isolates, as previously described (14).
Phylogenetic analysis.Maximum-likelihood phylogenetic trees were
constructed using RAxML v7.0.4 (14), with an alignment of all the con-
catenated variant sites from the nonrepetitive and nonrecombinant
genome included in the analyses as previously described (14). The maxi-
mum-likelihood ratios then were calculated using the general time-re-
versible model with a gamma correction for site variation as the nucleo-
tide substitution model. The likelihood test ratios were determined as
previously described (10). The support for nodes on the trees was checked
using 100 random bootstrap replicates. Resulting phylogenetic trees were
visualized using the FigTree package v1.4.0 (http://tree.bio.ed.ac.uk
/software/figtree/).
PacBio sequencing and assembly. Sequencing was performed using
the PacBio template preparation kit (PacBio, Menlo Park, CA, USA) by
following a modified version of the 20-kb template preparation using the
BluePippin size selection systemprotocol to prepare size-selected libraries
from 5 g of sheared DNA. Further sequencing was performed using the
magnetic bead collection protocol, a 20,000-bp insert size, stage start, and
180-min movies to set up the run protocol in RS Remote. In order to
capture smaller-sized plasmids, the 5-kb template preparation protocol
was applied. De novo assembly was performed using the standard SMRT
Analysis (v. 2.0.2) pipeline.
Plasmid genome analyses. The plasmid map was annotated using
DNAPlotter 10.2. The identity of genes of interest was confirmed using
NCBI tools, including BLAST.Mutations were detected using the protein
sequence alignment CLUSTALW program (15). The identification of be-
ta-lactamase gene mutations at the amino acid level was determined by
comparing the amino acid sequence of the sequenced enzyme to that of
the wild-type enzyme published at http://www.lahey.org/studies/.
Study ethical approval. Ethical approval for the study was obtained
from the KEMRI Ethical Review Committee (SSC no. 2027).
Nucleotide sequence accession numbers. Accession numbers for the
whole-genome short-read sequences for each of the isolates analyzed are the
following: 8947, ERR387652; 8944, ERR387655; 8942, ERR387656; 8948,
ERR387657; 8943, ERR387720; 8945, ERR387721; 8946, ERR387722; 5580,
ERR034067; 5597, ERR034068; 5575, ERR034078; 5582, ERR034079; 5576,
ERR034080; 5912, ERR034081; 5647, ERR034082; 5634, ERR034083; 5632,
ERR034084; 5581, ERR034086; 5578, ERR034087; 5577, ERR034088; A130,
ERR023781; 8891, ERR044726; 8892, ERR044727; D2358, FN424405; and
SL1344, FQ312003. The nucleotide sequence data for the pSBLT and
pKST313 plasmids were submitted to theNational Center for Biotechnology
Information Data Libraries (GenBank), and the sequences have been given
accession numbers LN794247 and LN794248, respectively.
RESULTS
Antimicrobial susceptibility and ESBL testing. The antimicro-
bial resistance profiles of the nine NTS isolates were identical,
regardless of the source. These isolates also were positive for ESBL
production by double disc synergy and MIC testing but were sus-
ceptible to ciprofloxacin and meropenem. In addition, all isolates
also were resistant to ampicillin, chloramphenicol, cefuroxime,
ceftriaxone, cefotaxime, aztreonam, cefepime, and sulfamethoxa-
zole-trimethoprim (Table 2).
TheESBL-producingNTS isolates are ST313.Whole-genome
sequence analyses of the nine isolates confirmed they belonged to
the same ST313 clade that has been isolated frequently in the sub-
SaharanAfrica region (10). Phylogenetic analyses based onwhole-
genome single-nucleotide polymorphisms (SNPs) assigned as
TABLE 1 Susceptibility profiles of S. Typhimurium isolates recovered from different specimen types and patient categories
Isolate
ID
Source
specimen Patient age Patient category Date of isolation
Susceptibility profilea
ESBL testNAL CIP CRO AMP CHL SXT
1891 Stool 43 yr Inpatient April 2010 S S R R R R Positive
8892 Urine 1 mo Inpatient May 2010 S S R R R R Positive
8943 Stool 2 yr Inpatient February 2012 S S R R R R Positive
8947 Stool 33 yr Outpatient October 2010 S S R R R R Positive
8942 Blood 4 yr Inpatient June 2009 S S R R R R Positive
8945 Stool Adult (age not known) Outpatient July 2009 S S R R R R Positive
8946 Stool Child (age not known) Outpatient December 2011 S S R R R R Positive
8944 Blood Child (age not known) Inpatient December 2011 S S R R R R Positive
8948 Stool Child (age not known) Outpatient December 2011 S S R R R R Positive
a Susceptibility profiles of isolates analyzed in this study. NAL, nalidixic acid; CIP, ciprofloxacin; CRO, ceftriaxone; AMP, ampicillin; CHL, chloramphenicol; SXT,
sulfamethoxazole-trimethoprim; ESBL test, ESBL status confirmed using the double disc synergy method. R, resistant; S, susceptible.
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previously reported for ST313 (10) showed that these ESBL-pro-
ducing strains fell into clade II and were highly related to the
reference ST313 invasive isolate D23580 from Malawi, with a
mean SNP difference of 39 (range, 31 to 70). A mean SNP differ-
ence between each pair of only 21 (range, 0 to 70) meant that the
nine isolates were even more closely related to each other than to
D23580 or any other representative S. Typhimurium lineages, in-
cluding the closest Kenyan strains described from previous out-
breaks (Fig. 1). Thus, these isolates potentially represent a clone
circulating within the study population. In addition, our pairwise
comparison also showed that seven of these isolates, 8942, 8944,
8947, 8943, 8945, 8946, and 8948, harbor minimal genome differ-
ences, represented by only a 1- or 2-SNP difference. The other two
isolates, 8891 and 8892, occupy a different branch of the tree and
were separated from the others by an average of 48 SNPs (range,
27 to 69) (Table 2).Overall, the low chromosomal SNPdifferences
indicate a clonal outbreak within the study population, especially
given the clustering away from the historical Kenyan ST313 iso-
lates on the tree (Fig. 1).
We next analyzed these isolates for characteristic genomic
markers that have been described for the ST313 lineages, includ-
ing plasmids, phage repertoire, and antibiotic resistance genes. A
pSLBT IncFII plasmid similar to the multidrug-resistant plasmid
found inD23580 (6) was identified in all isolates (Fig. 2A, i and ii).
TABLE 2 MICs of isolates analyzed
Isolate ID
MICa (g/ml)
CIP AMP SXT CRO CTX MEM FOX CPD FEP ATM
1891 0. 006 32 320 256 64 0.25 2 8 64 64
8892 0.012 32 320 256 64 0.25 2 8 64 .64
8943 0.25 32 320 64 64 0.25 8 8 64 64
8947 0.25 32 320 64 64 0.25 8 8 64 64
8942 0.25 32 320 64 64 0.25 8 8 64 64
8945 0.25 32 320 64 64 0.25 8 8 64 64
8946 0.25 32 320 64 64 0.25 8 8 64 64
8944 0.25 32 320 64 64 0.25 8 8 64 64
8948 0.25 32 320 64 64 0.25 8 8 64 64
a MICs against selected antimicrobials. CIP, ciprofloxacin; AMP, ampicillin; SXT, sulfamethoxazole-trimethoprim; CRO, ceftriaxone; CTX, cefotaxime; MEM, meropenem; FOX,
cefoxitin; CPD, cefpodoxime; FEP, cefepime; ATM, aztreonam.
FIG 1 Phylogenetic relationships between isolates. Unrooted maximum-likelihood tree showing the relationship between isolates (pink polygon) and other
Kenyan ST313 organisms isolated between 2003 and 2005 (10). D23580 (lineage II), A130 (lineage I), and the reference isolate SL1344 (ST19) are indicated on
the tree. Scale bars represent the number of substitutions that have occurred on each branch. The inset in panel B represents associated metadata of the isolate
arranged to reflect phylogenetic positioning.
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These isolates also contained a conserved repertoire of phages
similar to that of D23580 (Fig. 2B). The pSLBT plasmid carried
resistance determinants for aminoglycosides (aadA1), streptomy-
cin (strA and strB), -lactams (blaTEM-1), chloramphenicol
(catA1), trimethoprim (dhfr1), and sulfonamides (sul1 and sul2).
These resistance genes were located in a region containing a de-
generate Tn21 transposon (Fig. 3).
Carriage of IncHI2 plasmids among the ST313 isolates. In
addition to the pSLBT IncFII plasmid, the nine ESBL-producing
ST313 isolates contained an 300-kb IncHI2 plasmid, which we
designate pKST313 (for plasmid from the ST313 Kenyan strain).
pKST313 encodes two class 1 integrons, various transposons,
multiple insertion sequence (IS) elements, andmultiple resistance
cassettes (Fig. 4A and B). One region of the plasmid encodes re-
sistance to heavy-metals ions, including mercury (mer and tni
genes), tellurite (ter genes), arsenic (ars genes), and copper (cusS
and pcoE genes). This region also contained tellurite utilization
genes (tel genes). A second region harbors genes conferring resis-
FIG 2 Distributions of known virulence-associated determinants in isolates. (Ai) Spaces/gaps represent genes missing from some of the isolates. (Aii) Presence
of the Tn21-like region in pSLBT plasmids in the isolates. Numbers at the end of gene names represent accession codes for various genes associated with Tn21.
The genes found in the isolates are presented as heatmaps against various genes present in Tn21. Color gradients shows full coverage (with the darkest shade
representing 100% match) to no coverage (lightest shade representing 0% match) of the genes present in the Tn21-like region in pSLBT plasmids of the study
isolates against those found on a typical Tn21 region.
FIG 3 Genetic map of the pSLBT plasmid. Only genes with predicted functions are labeled. Genes involved in resistance to antimicrobials are labeled in blue.
Genes related to integrons, IS, and transposons are labeled in green. The first outer ring represents the forward open reading frame, the second inner ring shows
the reverse open reading frames, and the inner most circle is the % GC plot (yellow, above average; purple, below average).
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tance to antimicrobials, including aminoglycosides (aadA1),
streptomycin (strA and strB), -lactams (blaTEM-1), chloram-
phenicol (catA1), trimethoprim (dhfr1), and sulfonamides (sul1
and sul2), the majority of which are within a class 1 integron. The
third region (between trbN and traN) (Fig. 3) contained genes
responsible for plasmid replication, pilus formations, and conju-
gation. The gene encoding DNA repair protein UvrD also was
found adjacent to this region. This plasmid also contained multi-
ple ISs that include ISEcp1, associated with blaCTXM-15, the inte-
gron-associated IS26, IS4321 and IS5075, located near the mer-
cury resistance region, IS6100, and IS5.
Redundancy in antimicrobial resistance genes/cassettes.
These S. Typhimurium ST313 isolates carried multiple genes/cas-
settes conferring resistance to the same class of antimicrobials.
Such genes/cassettes included two copies of strA and strB (one pair
in the pSLBT plasmid and the other in the pKST313 plasmid)
conferring resistance to aminoglycosides. The catA1 gene (in
the pSLBT plasmid) and both catA1 and catB3 cassettes (in the
pKST313 plasmid) encode resistance to chloramphenicol. The
isolates also carried a combination of aac(6=)-Ib and a single copy
of aadA1 in each plasmid, all encoding resistance to aminoglyco-
sides. All of the isolates had multiple copies of -lactamases that
included blaTEM-1 in both plasmids, blaOXA-1 (that is poorly inhib-
ited by clavulanic acid), and blaCTX-M-15 (in pKST313). The dfrA1
cassette conferring resistance to trimethoprim was found in
pSLBT, while pKST313 carried another trimethoprim resistance
gene, dfrA14. The most redundant resistance sets of genes were
those conferring resistance to sulfonamides, with pKST313 carry-
ing both the sul1 and sul2 gene, while a second copy of sul2 was
located on the pKST313 plasmid.
DISCUSSION
Although ceftriaxone-resistant S. Typhimurium strains have been
reported previously in other countries in Europe (16), Asia (17,
18), and the United States (19, 20), few data are available on this
phenotype in sub-Saharan Africa. S. Typhimurium ST313 is the
dominant pathovariant of invasive NTS disease in immunocom-
promised adults and children in sub-Saharan Africa, and it is
noteworthy that the acquisition of this new plasmid has occurred
within this clonal population. We describe clonally related MDR
S. Typhimurium ST313 isolates from adults and children who
reported to a referral hospital with fever, with or without diarrhea,
and initially were treated with ceftriaxone and failed to respond.
The spectrum of resistance in these isolates extends beyond the
cephalosporins to include tetracyclines, chloramphenicol, and
aminoglycosides. Although high MIC values for cotrimoxazole,
cefotaxime, ceftriaxone, and aztreonam were recorded (Table 2),
these isolates remained susceptible to carbapenems and fluoro-
FIG 4 (A)Geneticmap of the pKST313 plasmid. Genes involved in resistance to antimicrobials are labeled in blue, while those related to (heavy)metal resistance
are labeled in purple. Genes related to integrons, IS, and transposons are labeled in green. The outer ring represents the forward open reading frames, the second
ring represents the reverse open reading frames, and the innermost circle is the % GC plot (yellow, above average; purple, below average). (B) Pairwise
comparisons of other IncHI2 plasmids. The innermost black ring 1 represents the reference sequence of pKST313. Six annotated plasmids with their respective
accession numbers used for the comparison are the following: ring 2, pAPEC-01-R (DQ517526); ring 3, pEC-IMPQ (EU855787); ring 4, pEC-IMP (EU855787);
ring 5, pSTM-A54650 (LK056646); ring 6, pK29 (EF382672); and ring 7 (the outermost ring), pR478 (BX664015). Gaps represent diversity from the reference
sequence (pKST313).
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quinolones. Locally, ceftriaxone has been the drug of choice for
use against iNTS that are resistant to commonly available antimi-
crobials. Interestingly, none of these isolates was found to contain
a cephamycin resistance gene, such as the blaCMY gene. These iso-
lates also were resistant to co-amoxiclav but did not carry any
known inhibitor resistance genes, such as those that encode inhib-
itor-resistant TEMs (IRTs). A possible explanation for these un-
expected observations is that these strains carry multiple copies of
bla genes, namely, blaOXA-1, blaTEM-1, and blaCTX-M-15 genes. The
blaOXA-1 gene has been reported to confer resistance to inhibitor
-lactams; therefore, the spread of this genemay limit the utility of
such agents (21). The blaCTX-M-15 gene detected in these isolates
encodes the most robust CTX-M-type ESBLs described to date
and has a wider hydrolytic capability againstmost cephalosporins,
including ceftazidime, than other CTX-Ms. The blaCTX-M-15 gene
was physically linked to the ISEcp1 element that has been impli-
cated in the expression and transposition of this gene and has been
linked to global dissemination in E. coli.
The NTS described in this study carried two plasmids that en-
code resistance to multiple antimicrobials. The pSLBT plasmid
also harbored multiple virulence genes and integron-borne resis-
tance determinants as previously described (6). However, thema-
jority of resistance genes in these isolates were borne on pKST313,
a significant portion of which is dedicated to antibiotic resistance
and resistance to heavy-metal ions. This plasmid could play a crit-
ical role in the persistence of NTS and other bacteria in environ-
ments heavily contaminated with detergents, heavy metals, and
other antimicrobials (22).
We found the Tn3-blaTEM-1-strB-strA-Sul2 gene motif, which
has been described as a promiscuous sequence that has the poten-
tial to spread to different types of plasmids. As reported in other
studies, this gene motif was closely associated with IS26 and
IS4321. The IS26-associated blaTEM-1-strB-strA-sul2 sequences
have been reported on other plasmids, such as pHCM1 (23) and
pAKU1 (24). Similar sequences also have been reported in other
IncF plasmids, such as the 120-kb IncF plasmid isolated in Ger-
many in 2005 (designated pRSB107) (25) and the IncF-like plas-
mid pU302L of S. Typhimurium G8430 (26).
Previous studies have indicated that bacteria bearing a combi-
nation of antimicrobial and heavy-metal resistance genes are re-
leased frompoorly treatedwastewater treatment plants (27, 28). It
is important to note that pKST313 shares over 80% of resistance
genes and (mobile) genetic elements with an IncHI2 (pK29) plas-
mid found in some clinical Klebsiella pneumoniae strains, while
the metal resistance region is similar to determinants found on
plasmids in E. coli, Pseudomonas spp., and the soil bacteria Rhizo-
bium spp. (29). These findings suggest that the novel plasmid orig-
inated from the environment and is a hybrid of different plasmids,
IS elements, and transposons brought together by recombination.
Comparative analysis indicates that IS26 detected inmultiple cop-
ies can act as a recombination junction between plasmid ancestors
that can lead to the emergence of new phenotypes.
In conclusion, we observed in Kenya the emergence of ceftri-
axone-resistant S. Typhimurium ST313 that has been associated
with an epidemic of invasive bacterial disease. This resistance and
MDR phenotype are borne in part on the pKST313 plasmid,
which contains integrative elements with the potential to rapidly
disseminate. These data highlight the threat of an epidemic shaped
by this new MDR phenotype.
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